ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY
LIVE

Serial Number

99677818

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

Mar 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY Trademark

Serial Number: 99677818

ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY is a trademark filed by Seqirus Inc. on March 2, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (88 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

March 2, 2026

Registration Date

Not Registered

Goods & Services

Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development

Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2026 CNRT
ASSIGNED TO EXAMINER
May 13, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 6, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 2, 2026 MAFR
NEW APPLICATION ENTERED
Mar 2, 2026 NWAP